10-Q | 2020-09-30 | Filed 2020-11-06 |
10-Q | 2020-06-30 | Filed 2020-08-10 |
10-Q | 2020-03-31 | Filed 2020-05-11 |
10-K | 2019-12-31 | Filed 2020-02-28 |
10-Q | 2019-09-30 | Filed 2019-11-07 |
10-Q | 2019-06-30 | Filed 2019-08-06 |
10-Q | 2019-03-31 | Filed 2019-05-10 |
10-K | 2018-12-31 | Filed 2019-02-28 |
10-Q | 2018-09-30 | Filed 2018-11-06 |
10-Q | 2018-06-30 | Filed 2018-08-06 |
10-Q | 2018-03-31 | Filed 2018-05-08 |
10-K | 2017-12-31 | Filed 2018-02-28 |
10-Q | 2017-09-30 | Filed 2017-11-08 |
10-Q | 2017-06-30 | Filed 2017-08-08 |
10-Q | 2017-03-31 | Filed 2017-05-09 |
10-K | 2016-12-31 | Filed 2017-02-28 |
10-Q | 2016-09-30 | Filed 2016-11-08 |
10-Q | 2016-06-30 | Filed 2016-08-08 |
10-Q | 2016-03-31 | Filed 2016-05-09 |
10-K | 2015-12-31 | Filed 2016-02-26 |
10-Q | 2015-09-30 | Filed 2015-11-12 |
10-Q | 2015-06-30 | Filed 2015-08-06 |
10-Q | 2015-03-31 | Filed 2015-05-07 |
10-K | 2014-12-31 | Filed 2015-03-05 |
10-Q | 2014-09-30 | Filed 2014-11-06 |
10-Q | 2014-06-30 | Filed 2014-08-07 |
10-Q | 2014-03-31 | Filed 2014-05-15 |
8-K | 2021-02-03 | Earnings, Regulation FD, Exhibits |
8-K | 2020-10-28 | |
8-K | 2020-10-14 | |
8-K | 2020-09-04 | |
8-K | 2020-07-30 | |
8-K | 2020-06-11 | |
8-K | 2020-06-10 | |
8-K | 2020-06-10 | |
8-K | 2020-05-19 | |
8-K | 2020-05-06 | |
8-K | 2020-04-13 | |
8-K | 2020-03-02 | |
8-K | 2020-02-05 | |
8-K | 2019-10-28 | |
8-K | 2019-08-06 | |
8-K | 2019-07-30 | |
8-K | 2019-06-10 | |
8-K | 2019-05-21 | |
8-K | 2019-04-25 | |
8-K | 2019-02-06 | |
8-K | 2018-10-22 | |
8-K | 2018-09-13 | |
8-K | 2018-07-24 | |
8-K | 2018-05-24 | |
8-K | 2018-04-25 | |
8-K | 2018-02-08 | |
8-K | 2018-01-06 |
Comps ($MM TTM) | Market Cap | Gross Margin | EV/EBITDA | Ret on Assets | Assets | Liabilities | Revenue | G Profit | Net Income | EBITDA | EV |
---|---|---|---|---|---|---|---|---|---|---|---|
20 20 Global (TWGL) | |||||||||||
024 Pharma (EEIG) | |||||||||||
111 (YI) | 0% | 1,546 | 323 | 0 | 0 | 0 | 0 | -854 | |||
1 800 Flowers Com (FLWS) | 944 | 42% | 13.3 | 6% | 665 | 336 | 1,266 | 534 | 37 | 75 | 1,001 |
10x Genomics (TXG) | 4,805 | 75% | -490.3 | -2% | 573 | 151 | 61 | 46 | -10 | -9 | 4,357 |
12 Retech (RETC) | 0 | 32% | -0.1 | -1,385% | 1 | 20 | 1 | 0 | -15 | -15 | 1 |
11 Good Energy (ELVN) | |||||||||||
1347 Property Insurance Holdings (PIH) | 34 | 0% | 0.4 | -5% | 164 | 108 | 18 | 0 | -8 | -8 | -3 |
1347 Capital Corp (TFSC) | |||||||||||
180 Degree Capital (TURN) | |||||||||||
1847 Holdings (EFSH) | 25% | -2.4 | -15% | 19 | 23 | 27 | 7 | -3 | -1 | 3 | |
1895 Bancorp of Wisconsin (BCOW) | 46,153 | 12,508.1 | -0% | 441 | 383 | 0 | 0 | -0 | 4 | 46,142 | |
1st Constitution Bancorp (FCCY) | 165 | 0% | 4.4 | 1% | 1,343 | 1,204 | 0 | 0 | 14 | 33 | 144 |
1st Franklin Financial (FFC) | 4 | -0.6 | 7% | 905 | 645 | 0 | 0 | 62 | 80 | -46 | |
24 7 Kid Doc (TVMD) | |||||||||||
1st Source (SRCE) | 1,200 | 7.9 | 1% | 6,691 | 5,858 | 0 | 0 | 70 | 136 | 1,073 | |
2050 Motors (ETFM) | 0 | -0.2 | -166,272,400% | 0 | 2 | 0 | 0 | -2 | -2 | 0 | |
21Vianet Group (VNET) | 6,005 | 0% | 11,151 | 5,788 | 0 | 0 | 0 | 0 | 3,344 | ||
22nd Century (XXII) | 302 | 1% | -14.1 | -36% | 62 | 7 | 26 | 0 | -22 | -21 | 302 |
1Life Healthcare (ONEM) |
Balance Sheet ($MM) | 2014-03-31 | 2014-06-30 | 2014-09-30 | 2014-12-31 | 2015-03-31 | 2015-06-30 | 2015-09-30 | 2015-12-31 | 2016-03-31 | 2016-06-30 | 2016-09-30 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
Cash | 113 | 207 | 212 | 202 | 188 | 196 | 153 | 169 | 203 | 133 | 178 | 240 | 275 | 293 | 266 | 234 | 276 | 447 | 298 | 216 | 194 | 364 | 399 |
Accounts Receivable | 38 | 38 | 43 | 36 | 50 | 46 | 44 | 42 | 51 | 57 | 66 | 61 | 62 | 60 | 74 | 96 | 100 | 98 | 120 | 111 | 141 | 124 | 123 |
Inventory | |||||||||||||||||||||||
PP&E | 36 | 38 | 40 | 34 | 37 | 25 | 29 | 30 | 38 | 49 | 63 | 69 | 79 | 89 | 100 | 117 | 132 | 146 | 173 | 198 | 228 | 256 | 284 |
Assets | 796 | 886 | 958 | 980 | 1,048 | 1,049 | 1,032 | 1,060 | 1,084 | 1,132 | 1,172 | 1,198 | 1,239 | 1,248 | 1,296 | 1,544 | 1,578 | 1,775 | 1,986 | 2,066 | 2,154 | 2,343 | 2,379 |
Accounts Payable | 3 | 2 | 2 | 3 | 4 | 2 | 4 | 8 | 4 | 11 | 10 | 8 | 10 | 8 | 12 | 8 | 12 | 9 | 17 | 27 | 16 | 22 | 23 |
Long-Term Debt | 174 | 148 | 123 | 297 | 342 | 340 | 500 | 500 | |||||||||||||||
Liabilities | 213 | 205 | 212 | 209 | 236 | 212 | 177 | 183 | 188 | 213 | 223 | 225 | 240 | 220 | 243 | 426 | 421 | 378 | 554 | 623 | 692 | 862 | 878 |
Stockholders' Equity | 548 | 681 | 746 | 771 | 812 | 837 | 856 | 878 | 896 | 919 | 950 | 972 | 999 | 1,028 | 1,053 | 1,118 | 1,157 | 1,396 | 1,432 | 1,442 | 1,462 | 1,482 | 1,501 |
Income Statement ($MM) | 2014-03-31 | 2014-06-30 | 2014-09-30 | 2014-12-31 | 2015-03-31 | 2015-06-30 | 2015-09-30 | 2015-12-31 | 2016-03-31 | 2016-06-30 | 2016-09-30 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
Revenue | 59 | 60 | 62 | 73 | 88 | 88 | 86 | 100 | 112 | 120 | 123 | 137 | 156 | 159 | 163 | 205 | 233 | 240 | 247 | 324 | 325 | 322 | |
Cost of Revenue | |||||||||||||||||||||||
Gross Profit | |||||||||||||||||||||||
R&D | |||||||||||||||||||||||
SG&A | 24 | 25 | 23 | 26 | 33 | 30 | 32 | 36 | 42 | 38 | 38 | 42 | 48 | 49 | 53 | 65 | 66 | 64 | 72 | 101 | 100 | 97 | |
Tax | 4 | 6 | 5 | 6 | 8 | 7 | 5 | 4 | 7 | 10 | 8 | 10 | 7 | 13 | 4 | 3 | 0 | 7 | 0 | 0 | 0 | -3 | |
Net Income | 4 | 3 | 6 | 11 | 11 | 9 | 7 | 11 | 10 | 13 | 13 | 14 | 18 | 15 | 13 | 54 | 31 | 30 | 23 | 7 | 1 | 1 | |
Cash Flow ($MM) | 2014-03-31 | 2014-06-30 | 2014-09-30 | 2014-12-31 | 2015-03-31 | 2015-06-30 | 2015-09-30 | 2015-12-31 | 2016-03-31 | 2016-06-30 | 2016-09-30 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
Cash Operating | 28 | 17 | 26 | 30 | 0 | -17 | 31 | 19 | 19 | 25 | 35 | 52 | 16 | 39 | 46 | 72 | 49 | 14 | 56 | 86 | |||
Cash Investing | -2 | -68 | -47 | -56 | -5 | -34 | -21 | 14 | -92 | 8 | 24 | -14 | -3 | -68 | -252 | -3 | -366 | -24 | -33 | -47 | |||
Cash Financing | 1 | 56 | 12 | 12 | 12 | 8 | 7 | 1 | 3 | 12 | 3 | -2 | 5 | 2 | 174 | -30 | 168 | -11 | 148 | -4 |